Drug-associated delirium in cancer patients

European Journal of Cancer, Supplement

Volumn 11, Issue 2, 2013, Pages 233-240

  Caraceni, Augusto ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; BUSPIRONE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; CYTARABINE; ERYTHROMYCIN; FLUOXETINE; FLUVOXAMINE; GEMCITABINE; ISOCARBOXAZID; LOXAPINE; METHOTREXATE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; MOTESANIB; NAVELBINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PENTAZOCINE; RISPERIDONE; RITUXIMAB; SERTRALINE; TRAMADOL; TRANYLCYPROMINE; UNINDEXED DRUG;

ACUTE PSYCHOSIS; ADVANCED CANCER; ALCOHOL ABUSE; AMNESIA; ANTICHOLINERGIC EFFECT; ATTENTION; BONE MARROW TRANSPLANTATION; BRAIN CORTEX; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; CONFUSION; DELIRIUM; DELIRIUM TREMENS; DELUSION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISORIENTATION; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FLAPPING TREMOR; HALLUCINATION; HOSPITAL PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INVOLUNTARY MOVEMENT; MENTAL HEALTH; MYOCLONUS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PERCEPTION DISORDER; POLYPHARMACY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; POSTOPERATIVE DELIRIUM; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR RETARDATION; QUALITY OF LIFE; RESTLESSNESS; SEROTONIN SYNDROME; SLEEP WAKING CYCLE; SOMNOLENCE; TREMOR;

EID: 84884935630     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2013.07.008     Document Type: Conference Paper

References (41)

1. Caraceni A., Scolari S., Simonetti F. The role of the neurologist in oncology a prospective study. J Neurol 1999, 246(Suppl. 1). I/68.
2. Caraceni A., Grassi L. Delirum: acute confusional stated in palliative medicine 2011, Oxford University Press, Oxford. 2nd ed.
3. Meagher D.J., Moran M., Bangaru R., et al. Phenomenology of delirium. Assessment of 100 adult cases using standardized measures. Br J Psychiatry 2007, 190:135-141.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Press, Text revision. DSM IV-TR. Washington. 4th edition.
5. Leonard M., Raju B., Conroy M., et al. Reversibility of delirium in terminally ill patients and predictors of mortality. Palliat Med 2008, 22:848-854.
6. Ljubisavjevic V., Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003, 25:345-352.
7. Hosie A., Davidson M.P., Agar M., Sanderson C.R., Phillips J. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med 2012, 27:486-498.
8. Gaudreau J., Gagnon P., Harel F., Tremblay A., Roy M. Fast, systematic and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005, 29:368-375.
9. Neufeld K., Leoutsakos J., Sieber F., et al. Evaluation of two delirium screening tools for detecting post-operative delirium in the elderly. Br J Anaesth 2013, 10.1093/bja/aet167.
10. Gaudreau J., Gagnon P., Harel F., Roy M. Impact on delirium detection of using a sensitive instrument integrated into clinical practice. Gen Hosp Psychiatry 2005, 27:194-199.
11. Tuma R., DeAngelis L.M. Altered mental status in patients with cancer. Arch Neurol 2000, 57:1727-1731.
12. Staykov D., Schwab S. Posterior reversible encephalopathy syndrome. J Int Care Medicine 2012, 27:11-24.
13. Graus F., Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol 2012, 25:795-801.
14. Gaudreau J., Gagnon P. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 2005, 64:471-475.
15. Lipowski Z.J. Etiology. Delirium: acute confusional states 1990, 109-140. Oxford University Press, New York, Oxford.
16. Inouye S.K., Charpentier P.A. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996, 275:852-857.
17. Caraceni A., Simonetti F. Palliating delirium in patients with cancer. Lancet Oncol 2009, 10:164-172.
18. Gaudreau J., Gagnon P., Roy M., Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005, 23:6712-6718.
19. Clegg A., Young J. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 2011, 40:23-29.
20. Itil T., Fink M. EEG and behavioral apects of the interaction of anticholinergic hallucinogens with centrally active compounds. Prog Brain Res 1968, 28:149-168.
21. Kurita G., Lundorff L., Pimenta C., Sjøgren P. The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer 2009, 17:11-21.
22. Hagen N., Swanson R. Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies. J Pain Symptom Manage 1997, 14:51-58.
23. Okon T., George M. Fentanyl-induced neurotoxicity and paradoxic pain. J Pain Symptom Manage 2008, 35:327-333.
24. Caraceni A., Martini C., De Conno F., Ventafridda V. Organic brain syndromes and opioid administration for cancer pain. J Pain Symptom Manage 1994, 9:527-533.
25. Bruera E., Schoeller T., Montejo G. Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 1992, 48:387-399.
26. King S., Forbes K., Hanks G., Ferro C., Chambers E. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med 2011, 25:525-552.
27. Breitbart W., Stiefel F., Kornblith A.B., Pannullo S. Neuropsychiatric disturbance in cancer patients with epidural spinal cord compression receiving high dose corticosteroids: a prospective comparison study. Psychooncology 1993, 2:233-245.
28. Stiefel F.C., Breitbart W.S., Holland J.C. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989, 7:479-491.
29. Bernard S.A., Bruera E. Drug interactions in palliative care. J Clin Oncol 2000, 18:1780-1799.
30. KuKanich B., Hubin M. The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogs. J Vet Pharmacol Ther 2010, 33:42-49.
31. Levin T.T., Bakr M.H., Nikolova T. Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction. Gen Hosp Psychiatry 2010, 32(648):e9-e10.
32. Tsao Y., Gugger J. Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine. Ann Pharmacother 2009, 43:1366-1369.
33. Ventafridda V., Ripamonti C., DeConno F., et al. Antidepressants increase bioavailability of morphine in cancer patients (letter). Lancet 1987, 1:1204.
34. Eckhardt K., Ammon S., Hofmann U., et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000, 91:185-191.
35. Scarpi E., Maltoni M., Miceli R., et al. Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium. Oncologist 2011, 16:1793-1799.
36. Lawlor P.G., Gagnon B., Mancini I.L., et al. Occurrence, causes and outcome of delirium in patients with advanced cancer. Arch Intern Med 2000, 160:786-794.
37. Morita T., Hirai K., Sakaguchi Y., Tsuneto S., Shima Y. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics 2004, 45:107-113.
38. Lonergan E, Britton A, Wyller T. Antipsychotics for delirium. Cochrane database of systematic reviews; 2007:Art.No:CD005594. doi: 10.1002/14651858.CD005594.
39. National Guidelines for Seniors' Mental Health: The Assessment and Treatment of Delirium. < 2006. (accessed 03.05.08). http://www.ccsmh.ca/en/guidelinesusers.cfm.
40. Casarett D., Inouye S. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001, 135:32-42.
41. Cook IA. Guideline Watch. Practice guideline for the treatment of delirium. Am Psych Assoc; 2004. Available from <. http://focus.psychiatryonline.org/content.aspx?bookid=28§ionid=1681952.